Filing Flows › Arvinas (ARVN) › R&D spending
Arvinas (ARVN) R&D spending by quarter
Arvinas' R&D spending was $46.9M in Q3 2026 (third quarter 2026), -11% from Q2 2026. Over the last 7 quarters it ranged from $46.9M (Q3 2026) to $90.8M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $46.9M | -11% | -28% |
| Q2 2026 | $52.6M | -13% | -23% |
| Q1 2026 | $60.3M | -1% | -34% |
| Q4 2025 | $61.1M | -6% | — |
| Q3 2025 | $64.7M | -6% | — |
| Q2 2025 | $68.6M | -24% | — |
| Q1 2025 | $90.8M | — | — |
Q3 2026 at a glance
Arvinas, Q3 2026: revenue $500K (-99% year over year), net loss $53.9M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arvinas' R&D spending?
Arvinas' R&D spending was $46.9M in Q3 2026 (third quarter 2026), -11% from Q2 2026.
How has Arvinas' R&D spending changed?
Over the last 7 quarters it ranged from $46.9M (Q3 2026) to $90.8M (Q1 2025).